<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39338474</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Analysis of Cultured Gut Microbiota Using MALDI-TOF MS in COVID-19 Patients from Serbia during the Predominance of the SARS-CoV-2 Omicron Variant.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1800</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12091800</ELocationID><Abstract><AbstractText>The currently dominant SARS-CoV-2 omicron variant, while causing mild respiratory symptoms, exhibits high transmissibility, drug resistance, and immune evasion. We investigated whether the presence of the SARS-CoV-2 affected the dynamics of fecal microbial composition isolated in culture in moderate COVID-19 patients. Blood, stool, and medical records were collected from 50 patients with confirmed SARS-CoV-2 infection. Two samples were taken per patient, at disease onset (within 5 days) and after symptom resolution (30-35 days). The part of the gut microbiota identifiable using MALDI-TOF MS was analyzed, and inflammatory cytokines and blood markers were measured in serum. The analysis identified 566 isolates at the species level, including 83 bacterial and 9 fungal species. Our findings indicate a change in the gut microbiota composition isolated in culture during the initial phase of infection, characterized by the proliferation of opportunistic bacteria such as <i>Enterococcus</i> spp. and <i>Citrobacter</i> spp., at the expense of beneficial commensal bacteria from the genus <i>Bacillus</i> and <i>Lactobacillus</i>. Additionally, the enrichment of fungal pathogens in fecal samples collected 30 days after the cessation of disease symptoms might suggest a prolonged disruption of the gut microbiota even after the resolution of COVID-19 symptoms. This study contributes to a growing body of evidence on the systemic effects of SARS-CoV-2 and highlights the importance of considering gastrointestinal involvement in the management and treatment of COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patić</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7068-2882</Identifier><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology with Parasitology and Immunology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovačević</LastName><ForeName>Gordana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuković</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9561-7825</Identifier><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hrnjaković Cvjetković</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology with Parasitology and Immunology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ristić</LastName><ForeName>Mioljub</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6923-189X</Identifier><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milosavljević</LastName><ForeName>Biljana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medić</LastName><ForeName>Deana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology with Parasitology and Immunology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Djilas</LastName><ForeName>Milan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radovanov</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovačević</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinic of Nephrology and Clinical Immunology, University Clinical Center of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pustahija</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balać</LastName><ForeName>Dragana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hygiene, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrović</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MALDI-TOF MS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338474</ArticleId><ArticleId IdType="pmc">PMC11433956</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12091800</ArticleId><ArticleId IdType="pii">microorganisms12091800</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sender R., Fuchs S., Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14:e1002533. doi: 10.1371/journal.pbio.1002533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002533</ArticleId><ArticleId IdType="pmc">PMC4991899</ArticleId><ArticleId IdType="pubmed">27541692</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain I., Cher G.L.Y., Abid M.A., Abid M.B. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential. Front. Immunol. 2021;12:765965. doi: 10.3389/fimmu.2021.765965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.765965</ArticleId><ArticleId IdType="pmc">PMC8551858</ArticleId><ArticleId IdType="pubmed">34721437</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzaal M., Saeed F., Shah Y.A., Hussain M., Rabail R., Socol C.T., Hassoun A., Pateiro M., Lorenzo J.M., Rusu A.V., et al. Human gut microbiota in health and disease: Unveiling the relationship. Front. Microbiol. 2022;26:999001. doi: 10.3389/fmicb.2022.999001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.999001</ArticleId><ArticleId IdType="pmc">PMC9549250</ArticleId><ArticleId IdType="pubmed">36225386</ArticleId></ArticleIdList></Reference><Reference><Citation>Syromyatnikov M., Nesterova E., Gladkikh M., Smirnova Y., Gryaznova M., Popov V. Characteristics of the Gut Bacterial Composition in People of Different Nationalities and Religions. Microorganisms. 2022;18:1866. doi: 10.3390/microorganisms10091866.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10091866</ArticleId><ArticleId IdType="pmc">PMC9501501</ArticleId><ArticleId IdType="pubmed">36144468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillman E.T., Lu H., Yao T., Nakatsu C.H. Microbial Ecology along the Gastrointestinal Tract. Microbes Environ. 2017;32:300–313. doi: 10.1264/jsme2.ME17017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1264/jsme2.ME17017</ArticleId><ArticleId IdType="pmc">PMC5745014</ArticleId><ArticleId IdType="pubmed">29129876</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou K., Wu Z.X., Chen X.Y., Wang J.Q., Zhang D., Xiao C., Zhu D., Koya J.B., Wei L., Li J., et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 2022;7:135. doi: 10.1038/s41392-022-00974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00974-4</ArticleId><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H.J., Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012;3:4–14. doi: 10.4161/gmic.19320.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/gmic.19320</ArticleId><ArticleId IdType="pmc">PMC3337124</ArticleId><ArticleId IdType="pubmed">22356853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiertsema S.P., van Bergenhenegouwen J., Garssen J., Knippels L.M.J. The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. Nutrients. 2021;13:886. doi: 10.3390/nu13030886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13030886</ArticleId><ArticleId IdType="pmc">PMC8001875</ArticleId><ArticleId IdType="pubmed">33803407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Q.X., Yaow C.Y.L., Moo J.R., Koo S.W.K., Loo E.X., Siah K.T.H. A systematic review of the association between environmental risk factors and the development of irritable bowel syndrome. J. Gastroenterol. Hepatol. 2024 doi: 10.1111/jgh.16587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.16587</ArticleId><ArticleId IdType="pubmed">38699957</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickard J.M., Zeng M.Y., Caruso R., Núñez G. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 2017;279:70–89. doi: 10.1111/imr.12567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12567</ArticleId><ArticleId IdType="pmc">PMC5657496</ArticleId><ArticleId IdType="pubmed">28856738</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y., Hand T.W. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121–141. doi: 10.1016/j.cell.2014.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.03.011</ArticleId><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhogaria B., Bhowmik P., Kundu A. Correlation between human gut microbiome and diseases. Infect. Med. 2022;1:180–191. doi: 10.1016/j.imj.2022.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imj.2022.08.004</ArticleId><ArticleId IdType="pmc">PMC10699709</ArticleId><ArticleId IdType="pubmed">38077626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., et al. Alterations in Gut Microbiota of Patients with COVID-19 during Time of Hospitalization. Gastroenterology. 2020;159:944–955.e8. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Giobbe G.G., Bonfante F., Jones B.C., Gagliano O., Luni C., Zambaiti E., Perin S., Laterza C., Busslinger G., Stuart H., et al. SARS-CoV-2 infection and replication in human gastric organoids. Nat. Commun. 2021;12:6610. doi: 10.1038/s41467-021-26762-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26762-2</ArticleId><ArticleId IdType="pmc">PMC8595698</ArticleId><ArticleId IdType="pubmed">34785679</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome R.C., Gauthier J., Hernandez M.C., Abraham G.E., Robinson T.O., Williams H.B., Sloan M., Owings A., Laird H., Christian T., et al. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut Microbes. 2021;1:1–15. doi: 10.1080/19490976.2021.1926840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1926840</ArticleId><ArticleId IdType="pmc">PMC8205023</ArticleId><ArticleId IdType="pubmed">34100340</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698–706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  World Health Organization Tracking SARS-CoV-2 Variants.  [(accessed on 26 June 2024)].  Available online:  https://www.who.int/en/activities/tracking-SARS-CoV-2-variants.</Citation></Reference><Reference><Citation>Wills C.P., Perez B., Moore J. Coronavirus Disease 2019: Past, Present, and Future. Emerg. Med. Clin. N. Am. 2024;42:415–442. doi: 10.1016/j.emc.2024.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.emc.2024.02.002</ArticleId><ArticleId IdType="pubmed">38641397</ArticleId></ArticleIdList></Reference><Reference><Citation>Infectious Diseases Society of America  “COVID-19 Variant Update”.  [(accessed on 26 June 2024)].  Available online:  https://www.idsociety.org/covid-19-real-time-learning-network/diagnostics/covid-19-variant-update/#/+/0/publishedDate_na_dt/desc/,GISAID.</Citation></Reference><Reference><Citation>Said E.A., Al-Reesi I., Al-Shizawi N., Jaju S., Al-Balushi M.S., Koh C.Y., Al-Jabri A.A., Jeyaseelan L. Defining IL-6 levels in healthy individuals: A meta-analysis. J. Med. Virol. 2021;93:3915–3924. doi: 10.1002/jmv.26654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26654</ArticleId><ArticleId IdType="pubmed">33155686</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarris A.H., Kliche K.O., Pethambaram P., Preti A., Tucker S., Jackow C., Messina O., Pugh W., Hagemeister F.B., McLaughlin P., et al. Interleukin-10 levels are often elevated in serum of adults with Hodgkin’s disease and are associated with inferior failure-free survival. Ann. Oncol. 1999;10:433–440. doi: 10.1023/A:1008301602785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1008301602785</ArticleId><ArticleId IdType="pubmed">10370786</ArticleId></ArticleIdList></Reference><Reference><Citation>Alecu M., Geleriu L., Coman G., Gălăţescu L. The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis. Rom. J. Intern. Med. 1998;36:251–259.</Citation><ArticleIdList><ArticleId IdType="pubmed">10822522</ArticleId></ArticleIdList></Reference><Reference><Citation>OurWorldInData  SARS-CoV-2 Sequences by Variant, Serbia. 21 November 2022.  [(accessed on 26 June 2024)].  Available online:  https://ourworldindata.org/grapher/covid-variants-bar?country=~SRB.</Citation></Reference><Reference><Citation>Natarajan A., Zlitni S., Brooks E.F., Vance S.E., Dahlen A., Hedlin H., Park R.M., Han A., Schmidtke D.T., Verma R., et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3:371–387.e9. doi: 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Antia A., Alvarado D.M., Zeng Q., Casorla-Perez L.A., Davis D.L., Sonnek N.M., Ciorba M.A., Ding S. SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells. Viruses. 2024;16:634. doi: 10.3390/v16040634.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16040634</ArticleId><ArticleId IdType="pmc">PMC11055019</ArticleId><ArticleId IdType="pubmed">38675974</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Corona N.C., López-Ortega O., Pérez-Martínez C.A., Martínez-Castillo M., De Jesús-González L.A., León-Reyes G., León-Juárez M. Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome. Int. J. Mol. Sci. 2023;24:14822. doi: 10.3390/ijms241914822.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241914822</ArticleId><ArticleId IdType="pmc">PMC10573029</ArticleId><ArticleId IdType="pubmed">37834270</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan N., Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ. 2019;7:e7502. doi: 10.7717/peerj.7502.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.7502</ArticleId><ArticleId IdType="pmc">PMC6699480</ArticleId><ArticleId IdType="pubmed">31440436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardi T., Pintado V., Gomez-Rojo M., Escudero-Sanchez R., Azzam Lopez A., Diez-Remesal Y., Martinez Castro N., Ruiz-Garbajosa P., Pestaña D. Nosocomial Infections Associated to COVID-19 in the Intensive Care Unit: Clinical Characteristics and Outcome. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:495–502. doi: 10.1007/s10096-020-04142-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04142-w</ArticleId><ArticleId IdType="pmc">PMC7778834</ArticleId><ArticleId IdType="pubmed">33389263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoletti M., Giannella M., Scudeller L., Tedeschi S., Rinaldi M., Bussini L., Fornaro G., Pascale R., Pancaldi L., Pasquini Z., et al. Development and Validation of a Prediction Model for Severe Respiratory Failure in Hospitalized Patients With SARS-CoV-2 Infection: A Multicenter Cohort Study (PREDI-CO Study) Clin. Microbiol. Infect. 2020;26:1545–1553. doi: 10.1016/j.cmi.2020.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC7414420</ArticleId><ArticleId IdType="pubmed">32781244</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeeva J.S., Fedorov D.E., Starikova E.V., Manolov A.I., Pavlenko A.V., Selezneva O.V., Klimina K.M., Veselovsky V.A., Morozov M.D., Yanushevich O.O., et al. Microbial Signatures in COVID-19: Distinguishing Mild and Severe Disease via Gut Microbiota. Biomedicines. 2024;12:996. doi: 10.3390/biomedicines12050996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12050996</ArticleId><ArticleId IdType="pmc">PMC11118803</ArticleId><ArticleId IdType="pubmed">38790958</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaibani P., D’Amico F., Bartoletti M., Lombardo D., Rampelli S., Fornaro G., Coladonato S., Siniscalchi A., Re M.C., Viale P., et al. The Gut Microbiota of Critically Ill Patients with COVID-19. Front. Cell Infect. Microbiol. 2021;11:670424. doi: 10.3389/fcimb.2021.670424.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.670424</ArticleId><ArticleId IdType="pmc">PMC8276076</ArticleId><ArticleId IdType="pubmed">34268136</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariq F.N., Shafiq M., Khawar N., Habib G., Gul H., Hayat A., Rehman M.U., Moussa I.M., Mahmoud E.A., Elansary H.O. The functional repertoire of AmpR in the AmpC β-lactamase high expression and decreasing β-lactam and aminoglycosides resistance in ESBL Citrobacter freundii. Heliyon. 2023;9:e19486. doi: 10.1016/j.heliyon.2023.e19486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e19486</ArticleId><ArticleId IdType="pmc">PMC10472055</ArticleId><ArticleId IdType="pubmed">37662790</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiopu P., Toc D.A., Colosi I.A., Costache C., Ruospo G., Berar G., Gălbău S.G., Ghilea A.C., Botan A., Pană A.G., et al. An Overview of the Factors Involved in Biofilm Production by the Enterococcus Genus. Int. J. Mol. Sci. 2023;24:11577. doi: 10.3390/ijms241411577.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241411577</ArticleId><ArticleId IdType="pmc">PMC10380289</ArticleId><ArticleId IdType="pubmed">37511337</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux C.A., Lagier J.C., Raoult D. New insights into the physiopathology of COVID-19: SARS-CoV-2-associated gastrointestinal illness. Front. Med. 2021;8:640073. doi: 10.3389/fmed.2021.640073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.640073</ArticleId><ArticleId IdType="pmc">PMC7930624</ArticleId><ArticleId IdType="pubmed">33681266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiqul Islam S.M., Foysal M.J., Hoque M.N., Mehedi H.H., Rob M.A., Salauddin A., Tanzina A.Y., Biswas S., Noyon S.H., Siddiki A.Z., et al. Dysbiosis of oral and gut microbiomes in SARS-CoV-2 infected patients in Bangladesh: Elucidating the role of opportunistic gut microbes. Front. Med. 2022;9:821777. doi: 10.3389/fmed.2022.821777.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.821777</ArticleId><ArticleId IdType="pmc">PMC8882723</ArticleId><ArticleId IdType="pubmed">35237631</ArticleId></ArticleIdList></Reference><Reference><Citation>Toc D.A., Mihaila R.M., Botan A., Bobohalma C.N., Risteiu G.A., Simut-Cacuci B.N., Steorobelea B., Troanca S., Junie L.M. Enterococcus and COVID-19: The Emergence of a Perfect Storm? Int. J. Transl. Med. 2022;2:220–229. doi: 10.3390/ijtm2020020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijtm2020020</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacobbe D.R., Labate L., Tutino S., Baldi F., Russo C., Robba C., Ball L., Dettori S., Marchese A., Dentone C., et al. Enterococcal bloodstream infections in critically ill patients with COVID-19: A case series. Ann. Med. 2021;53:1779–1786. doi: 10.1080/07853890.2021.1988695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2021.1988695</ArticleId><ArticleId IdType="pmc">PMC8519517</ArticleId><ArticleId IdType="pubmed">34637370</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveen K.V., Saravanakumar K., Sathiyaseelan A., MubarakAli D., Wang M.H. Human fungal infection, immune response, and clinical challenge—A perspective during COVID-19 pandemic. Appl. Biochem. Biotechnol. 2022;194:4244–4257. doi: 10.1007/s12010-022-03979-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12010-022-03979-5</ArticleId><ArticleId IdType="pmc">PMC9156836</ArticleId><ArticleId IdType="pubmed">35648275</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda Y., Motooka D., Kawasaki T., Oki H., Noda Y., Adachi Y., Niitsu T., Okamoto S., Tanaka K., Fukushima K., et al. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity. BMC Infect. Dis. 2022;22:572. doi: 10.1186/s12879-022-07358-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07358-7</ArticleId><ArticleId IdType="pmc">PMC9233337</ArticleId><ArticleId IdType="pubmed">35751044</ArticleId></ArticleIdList></Reference><Reference><Citation>Granata G., Schiavone F., Pipitone G., Taglietti F., Petrosillo N. Antibiotics Use in COVID-19 Patients: A Systematic Literature Review. J. Clin. Med. 2022;11:7207. doi: 10.3390/jcm11237207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11237207</ArticleId><ArticleId IdType="pmc">PMC9739751</ArticleId><ArticleId IdType="pubmed">36498781</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B., Ueland T., Lerum T.V., Dahl T.B., Holm K., Barratt-Due A., Kåsine T., Dyrhol-Riise A.M., Stiksrud B., Tonby K., et al. Respiratory Dysfunction Three Months after Severe COVID-19 Is Associated with Gut Microbiota Alterations. J. Intern. Med. 2022;291:801–812. doi: 10.1111/joim.13458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13458</ArticleId><ArticleId IdType="pmc">PMC9115297</ArticleId><ArticleId IdType="pubmed">35212063</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar D., Mohanty A. Gut microbiota and COVID-19- possible link and implications. Virus Res. 2020;285:198018. doi: 10.1016/j.virusres.2020.198018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198018</ArticleId><ArticleId IdType="pmc">PMC7217790</ArticleId><ArticleId IdType="pubmed">32430279</ArticleId></ArticleIdList></Reference><Reference><Citation>Morais A.H.A., Passos T.S., Maciel B.L.L., da Silva-Maia J.K. Can Probiotics and Diet Promote Beneficial Immune Modulation and Purine Control in Coronavirus Infection? Nutrients. 2020;12:1737. doi: 10.3390/nu12061737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061737</ArticleId><ArticleId IdType="pmc">PMC7352643</ArticleId><ArticleId IdType="pubmed">32532069</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciel-Fiuza M.F., Muller G.C., Campos D.M.S., do Socorro Silva Costa P., Peruzzo J., Bonamigo R.R., Veit T., Vianna F.S.L. Role of gut microbiota in infectious and inflammatory diseases. Front. Microbiol. 2023;14:1098386. doi: 10.3389/fmicb.2023.1098386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1098386</ArticleId><ArticleId IdType="pmc">PMC10083300</ArticleId><ArticleId IdType="pubmed">37051522</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Liao W., Wan L., Xiang T., Zhang W. Correlation between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19. Viral Immunol. 2021;34:330–335. doi: 10.1089/vim.2020.0062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2020.0062</ArticleId><ArticleId IdType="pubmed">32297828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff W.E., Greiling T.M., Kriegel M.A. Host–microbiota interactions in immune-mediated diseases. Nat. Rev. Microbiol. 2020;18:521–538. doi: 10.1038/s41579-020-0367-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-0367-2</ArticleId><ArticleId IdType="pubmed">32457482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutfi L.L., Shaaban M.I., Elshaer S.L. Vitamin D and vitamin K1 as novel inhibitors of biofilm in Gram-negative bacteria. BMC Microbiol. 2024;24:173. doi: 10.1186/s12866-024-03293-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-024-03293-6</ArticleId><ArticleId IdType="pmc">PMC11102130</ArticleId><ArticleId IdType="pubmed">38762474</ArticleId></ArticleIdList></Reference><Reference><Citation>Zsichla L., Müller V. Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors. Viruses. 2023;15:175. doi: 10.3390/v15010175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010175</ArticleId><ArticleId IdType="pmc">PMC9863423</ArticleId><ArticleId IdType="pubmed">36680215</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Q.X., Yau C.E., Yaow C.Y.L., Chong R.I.H., Chong N.Z., Teoh S.E., Lim Y.L., Soh A.Y.S., Ng W.K., Thumboo J. What Has Longitudinal ‘Omics’ Studies Taught Us about Irritable Bowel Syndrome? A Systematic Review. Metabolites. 2023;13:484. doi: 10.3390/metabo13040484.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13040484</ArticleId><ArticleId IdType="pmc">PMC10142038</ArticleId><ArticleId IdType="pubmed">37110143</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncanson K., Williams G., Hoedt E.C., Collins C.E., Keely S., Talley N.J. Diet-microbiota associations in gastrointestinal research: A systematic review. Gut Microbes. 2024;16:2350785. doi: 10.1080/19490976.2024.2350785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2024.2350785</ArticleId><ArticleId IdType="pmc">PMC11093048</ArticleId><ArticleId IdType="pubmed">38725230</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>